Survey results show labeling is critical to medical device companies
A 2015 survey carried out by PRISYM ID into the key labeling challenges for the medical device and life sciences industries, has identified regulatory compliance and supply chain efficiency as the key drivers for organizations needing to change or adapt their packaging and labeling operations.
With Class II UDI regulations requiring compliance in 2015 and 2016, it’s no surprise that this continues to be a priority for many companies.
More than 60% of those companies surveyed cited the labeling of products as ‘business critical’ to the supply chain and their organization. Maintaining an efficient supply chain is widely acknowledged as a key strategic imperative for businesses across the global medical device and life science sectors. Companies are under intense pressure to reduce costs, curb wastage and increase productivity – and to develop more agile operations that can respond to changes in the global marketplace.
70% of companies suggested that they would need to make changes to existing operations in order to meet the regulatory demands. More concerning however is that 40% of those organizations surveyed were either not confident or unsure as to whether their existing labeling process were sufficient, which suggests there is still some work to be done in order to control these issues.